Cargando…

B Cell Lymphocytosis in Juvenile Dermatomyositis

In this study, we determined if B lymphocytosis may serve as a JDM biomarker for disease activity. Children with untreated JDM were divided into two groups based on age-adjusted B cell percentage (determined through flow cytometry): 90 JDM in the normal B cell group and 45 in the high B cell group....

Descripción completa

Detalles Bibliográficos
Autores principales:	Costin, Christopher, Khojah, Amer, Ochfeld, Elisa, Morgan, Gabrielle, Subramanian, Saravanan, Klein-Gitelman, Marisa, Tan, Xiao-Di, Pachman, Lauren M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453137/ https://www.ncbi.nlm.nih.gov/pubmed/37627885 http://dx.doi.org/10.3390/diagnostics13162626

Ejemplares similares

Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
por: Costin, Christopher, et al.
Publicado: (2023)

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
por: Pachman, Lauren M., et al.
Publicado: (2023)

Juvenile Dermatomyositis: Association between Nail Fold Capillary End Row Loops Area Under the Curve and Disease Damage Indicators
por: Khojah, Amer, et al.
Publicado: (2023)

Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators
por: Khojah, Amer, et al.
Publicado: (2023)

Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept study
por: Ochfeld, Elisa, et al.
Publicado: (2022)

Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers
por: Khojah, Amer, et al.
Publicado: (2021)

Increased Otoferlin Expression in B Cells Is Associated with Muscle Weakness in Untreated Juvenile Dermatomyositis: A Pilot Study
por: Bukhari, Ameera, et al.
Publicado: (2023)

The von Willebrand Factor Antigen Reflects the Juvenile Dermatomyositis Disease Activity Score
por: Gibbs, Ellie, et al.
Publicado: (2023)

Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids
por: Khojah, Amer, et al.
Publicado: (2021)

Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy
por: Pachman, Lauren M., et al.
Publicado: (2021)

Serum protein biomarkers for juvenile dermatomyositis: a pilot study
por: Tawalbeh, Shefa M., et al.
Publicado: (2020)

Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study
por: Xu, Dong, et al.
Publicado: (2017)

Evidence for Resident Memory T cells in Rasmussen Encephalitis
por: Khojah, Amer, et al.
Publicado: (2016)

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis
por: Duvvuri, Bhargavi, et al.
Publicado: (2023)

Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
por: Khojah, Amer M., et al.
Publicado: (2019)

Monoclonal B-cell Lymphocytosis Exacerbated by Prednisolone Therapy for Dermatomyositis
por: Kume, Ayaka, et al.
Publicado: (2021)

Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive
por: Roberson, Elisha D. O., et al.
Publicado: (2022)

Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis
por: Chen, Yi-Wen, et al.
Publicado: (2008)

Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis
por: Conklin, Laurie S., et al.
Publicado: (2018)

Juvenile Dermatomyositis
por: Rhim, Jung Woo
Publicado: (2022)

Juvenile Dermatomyositis in Pregnancy
por: Madu, Anthony Emeka, et al.
Publicado: (2013)

The Vasculopathy of Juvenile Dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2018)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020)

Juvenile Dermatomyositis—Clinical Phenotypes
por: Li, Danyang, et al.
Publicado: (2019)

The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)

Clinically Amyopathic Juvenile Dermatomyositis
por: Yıldırım, Deniz Gezgin, et al.
Publicado: (2023)

Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research
por: McCann, Liza J, et al.
Publicado: (2018)

Infectious Lymphocytosis
por: McCollum, J. Kinloch
Publicado: (1949)

The Lymphocytosis of Infection
por: Wilson-Smith, T.
Publicado: (1928)

Monoclonal B-Cell Lymphocytosis
por: D’Arena, G., et al.
Publicado: (2014)

Monoclonal B-cell lymphocytosis()
por: Biasoli, Irene, et al.
Publicado: (2015)

Prevalence and Immunophenotypic Characteristics of Monoclonal B-Cell Lymphocytosis in Healthy Korean Individuals With Lymphocytosis
por: Yoo, In Young, et al.
Publicado: (2020)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Dyslipidemia in active juvenile dermatomyositis patients
por: Kozu, KT, et al.
Publicado: (2011)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jqh9bq0d6gq2n4v72ivsfd5oa2